- Home
- UNB vs ALEC Comparison
UNB vs ALEC Comparison
Compare UNB & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNB
- ALEC
- Stock Information
- Founded
- UNB 1891
- ALEC 2013
- Country
- UNB United States
- ALEC United States
- Employees
- UNB N/A
- ALEC N/A
- Industry
- UNB Major Banks
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UNB Finance
- ALEC Health Care
- Exchange
- UNB Nasdaq
- ALEC Nasdaq
- Market Cap
- UNB 117.7M
- ALEC 124.0M
- IPO Year
- UNB 1998
- ALEC 2019
- Fundamental
- Price
- UNB $25.33
- ALEC $3.08
- Analyst Decision
- UNB
- ALEC Buy
- Analyst Count
- UNB 0
- ALEC 7
- Target Price
- UNB N/A
- ALEC $4.50
- AVG Volume (30 Days)
- UNB 11.2K
- ALEC 1.3M
- Earning Date
- UNB 10-20-2025
- ALEC 11-05-2025
- Dividend Yield
- UNB 5.78%
- ALEC N/A
- EPS Growth
- UNB N/A
- ALEC N/A
- EPS
- UNB 2.01
- ALEC N/A
- Revenue
- UNB $48,950,000.00
- ALEC $81,130,000.00
- Revenue This Year
- UNB N/A
- ALEC N/A
- Revenue Next Year
- UNB N/A
- ALEC $290.50
- P/E Ratio
- UNB $12.54
- ALEC N/A
- Revenue Growth
- UNB 2.99
- ALEC 46.77
- 52 Week Low
- UNB $24.50
- ALEC $0.87
- 52 Week High
- UNB $37.70
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- UNB N/A
- ALEC 57.52
- Support Level
- UNB N/A
- ALEC $3.04
- Resistance Level
- UNB N/A
- ALEC $3.33
- Average True Range (ATR)
- UNB 0.00
- ALEC 0.20
- MACD
- UNB 0.00
- ALEC -0.03
- Stochastic Oscillator
- UNB 0.00
- ALEC 63.00
About UNB Union Bankshares Inc.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.